The lead LSF inhibitor, FQI1, induces apoptosis in hepatocellular carcinoma cell lines in vitro as a consequence of mitotic defects and significantly inhibits tumor growth in multiple mouse hepatocellular carcinoma models, with no observable toxicity to normal tissues (31, 35). The gene discussed is TFCP2; the disease is neoplasm.